Investigational Site Number 8104
Saitama
0 studies enrolling now · 2 studies all time
What they study most
Hemophilia, Hemophilia A, Hemophilia B
Studies at this site
A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis
— Completed
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
— Completed